Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samantha Vanderslott

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
BMJ (Clinical Research Ed.)|August 19, 2025
WHO pandemic agreementAlice Norton, Samantha Vanderslott, Peter Horby
Vaccines|April 30, 2021
MMR Vaccine Attitude and Uptake Research in the United Kingdom: A Critical ReviewLouis Torracinta, Rachel Tanner, Samantha Vanderslott
Economy and Society|March 19, 2025
Effective altruism, technoscience and the making of philanthropic valueApolline Taillandier, Neil Stephens, Samantha Vanderslott
BMJ Public Health|February 28, 2025
Representation of ethnic and racial minority groups in European vaccine trials: a quantitative analysis of clinical trials registriesNatasha F Puttick, Samantha Vanderslott, Rachel Tanner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2019
Typhoid-From Past to FutureClaas Kirchhelle, Andrew J Pollard, Samantha Vanderslott
NPJ Digital Medicine|July 12, 2025
A systematic review on patient and public attitudes toward health monitoring technologies across countriesTiantian Chen, Ekaterina Hertog, Adam Mahdi, et al.
Social Science & Medicine (1982)|November 20, 2023
Online on the frontline: A longitudinal social media analysis of UK healthcare workers' attitudes to COVID-19 vaccines using the 5C frameworkNoémie Déom, Samantha Vanderslott, Patricia Kingori, et al.
The Lancet. Infectious Diseases|June 25, 2022
Addressing vaccine inequities among Ukrainian refugeesMatilda Hill, Samantha Vanderslott, Alla Volokha, et al.
JAAD International|January 22, 2026
En-risk to de-risk: An iterative human factors framework for scale development in emerging technologiesJonathan Kantor, Michael Morrison, Samantha Vanderslott, et al.
Vaccines|December 24, 2025
Discriminative Cut-Offs, Concurrent Criterion Validity, and Test-Retest Reliability of the Oxford Vaccine Hesitancy ScaleJonathan Kantor, Samantha Vanderslott, Michael Morrison, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
BMJ (Clinical Research Ed.)|August 19, 2025
WHO pandemic agreementAlice Norton, Samantha Vanderslott, Peter Horby
Vaccines|April 30, 2021
MMR Vaccine Attitude and Uptake Research in the United Kingdom: A Critical ReviewLouis Torracinta, Rachel Tanner, Samantha Vanderslott
Economy and Society|March 19, 2025
Effective altruism, technoscience and the making of philanthropic valueApolline Taillandier, Neil Stephens, Samantha Vanderslott
BMJ Public Health|February 28, 2025
Representation of ethnic and racial minority groups in European vaccine trials: a quantitative analysis of clinical trials registriesNatasha F Puttick, Samantha Vanderslott, Rachel Tanner
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2019
Typhoid-From Past to FutureClaas Kirchhelle, Andrew J Pollard, Samantha Vanderslott
NPJ Digital Medicine|July 12, 2025
A systematic review on patient and public attitudes toward health monitoring technologies across countriesTiantian Chen, Ekaterina Hertog, Adam Mahdi, et al.
Social Science & Medicine (1982)|November 20, 2023
Online on the frontline: A longitudinal social media analysis of UK healthcare workers' attitudes to COVID-19 vaccines using the 5C frameworkNoémie Déom, Samantha Vanderslott, Patricia Kingori, et al.
The Lancet. Infectious Diseases|June 25, 2022
Addressing vaccine inequities among Ukrainian refugeesMatilda Hill, Samantha Vanderslott, Alla Volokha, et al.
JAAD International|January 22, 2026
En-risk to de-risk: An iterative human factors framework for scale development in emerging technologiesJonathan Kantor, Michael Morrison, Samantha Vanderslott, et al.
Vaccines|December 24, 2025
Discriminative Cut-Offs, Concurrent Criterion Validity, and Test-Retest Reliability of the Oxford Vaccine Hesitancy ScaleJonathan Kantor, Samantha Vanderslott, Michael Morrison, et al.
Pageof 7